![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
U Forstermann, LD Gorsky, JS Pollock, K Ishii, HH Schmidt, M Heller and F Murad
Abbott Laboratories, Abbott Park, Illinois 60064.
Stimulation of soluble guanylyl cyclase in rat fetal lung fibroblasts (RFL-6 cells) was used as a sensitive assay for endothelium-derived relaxing factor/nitric oxide (EDRF/NO) formation. Intact N1E-115 cells released an EDRF/NO-like material that enhanced cyclic GMP levels in RFL-6 cells. The synthesis of this substance could be stimulated with the receptor agonist neurotensin (10 microM) or by addition of the EDRF/NO substrate L-arginine (100 microM). In Ca2(+)-free Locke's solution, stimulation of EDRF/NO production by both neurotensin and L- arginine was abolished. The EDRF/NO-synthesizing activity was localized in the cytosol of N1E-115 cells. The activity was lost after boiling and it was highly sensitive to Ca2+ with the major increase in activity occurring between 100 and 500 nM Ca2+. L-Arginine and NADPH were required for maximal synthesis of EDRF/NO by the enzyme(s). The synthesis of EDRF/NO was inhibited by the following antagonists of calmodulin-regulated functions (with the approximate IC50 values given in parentheses): calmidazolium (7 microM), trifluoperazine (10 microM), fendiline (80 microM), W-7 (N-[6-aminohexyl]-5-chloro-1- naphthalenesulfonamide) (120 microM), and compound 48/80 (3 micrograms/ml). The EDRF/NO-synthesizing activity was partially purified from N1E-115 cytosol by DE 52 anion exchange chromatography. The activity was eluted with 0.1 M KCl. The enzyme(s) showed very little activity in the presence of L-arginine (100 microM) and NADPH (100 microM), but the activity could be fully restored by addition of exogenous calmodulin (EC50, approximately 2 units/ml). At 0.3 M KCl, a fraction eluted from the DE 52 column that was also able to fully restore the EDRF/NO-synthesizing activity. Thus, this fraction is likely to contain the endogenous Ca2(+)-binding protein. It is concluded that the activity of the EDRF/NO-synthesizing enzyme(s) in N1E-115 neuroblastoma cells is regulated by Ca2+ and calmodulin.
This article has been cited by other articles:
|
|
 |
|
  B. Trivedi and R. H. Kramer Patch Cramming Reveals the Mechanism of Long-Term Suppression of Cyclic Nucleotides in Intact Neurons J. Neurosci., October 15, 2002; 22(20): 8819 - 8826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Blond, H. Raoul, R. Le Grand, and D. Dormont Nitric Oxide Synthesis Enhances Human Immunodeficiency Virus Replication in Primary Human Macrophages J. Virol., October 1, 2000; 74(19): 8904 - 8912. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. M. Schwarz, B. Gierten, J.-P. Boissel, and U. Förstermann Expressional Down-Regulation of Neuronal-Type Nitric Oxide Synthase I by Glucocorticoids in N1E-115 Neuroblastoma Cells Mol. Pharmacol., August 1, 1998; 54(2): 258 - 263. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Schaeffer, M.-C. Laplace, P. Savi, A.-M. Pflieger, D. Gully, and J.-M. Herbert Human Umbilical Vein Endothelial Cells Express High Affinity Neurotensin Receptors Coupled to Intracellular Calcium Release J. Biol. Chem., February 17, 1995; 270(7): 3409 - 3413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schmidt, T. Warner, K Ishii, H Sheng, and F Murad Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides Science, February 7, 1992; 255(5045): 721 - 723. [Abstract] [PDF]
|
|
|
|
|
|
M. Morales-Ruiz, M.-J. Lee, S. Zollner, J.-P. Gratton, R. Scotland, I. Shiojima, K. Walsh, T. Hla, and W. C. Sessa Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a Gi Protein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells J. Biol. Chem., May 25, 2001; 276(22): 19672 - 19677. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
